Overall rank by patents
#41,393
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
LUX BIO Group Inc.
USPTO PatentsView assignee record - 6 granted patents across 5 technology areas, active 2015–2019. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES).
6
Total patents granted
5
CPC technology areas
16.3
Avg claims per patent
-100%
5-year filing velocity
The verdict
LUX holds 6 US patents across 5 technology areas, rank #41,393 of 50,000 tracked assignees.
- #41,393
- of 50,000 US assignees by volume
- Top 85%
- by Innovation Score (24.4/100)
- 16.3
- avg claims per patent
- -100%
- filing velocity, last 5 yrs
Portfolio overview
LUX BIO Group Inc. has been granted 6 US utility patents between 2015 and 2019, placing LUX BIO Group Inc. at rank #41,393 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES). As a US Corporation, LUX BIO Group Inc. is one of the more focused assignees in the PatentsView dataset. By volume, LUX sits between Luminous Cyber Corporation (6 patents, rank #41,389) and Laaser Critical Communications Corp. (6 patents, rank #41,397) - the closest US assignees by grant volume. The composite Innovation Score of 24.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 0 grants, compared with 6 in the 2015–2019 window, a -100% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. LUX BIO Group Inc.'s 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark LUX BIO Group Inc. against peers pursuing similar technology classes.
Who files at LUX's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Luminous Cyber
LUMINOUS CYBER CORPORATION
6 patents
- Lumos LABS
LUMOS LABS, INC.
6 patents
- Lumosa Therapeuti…
LUMOSA THERAPEUTICS CO., LTD
6 patents
- LURE Enterprises…
LURE ENTERPRISES LIMITED LIABILITY COMPANY
6 patents
- LWE
LWE, Inc.
6 patents
- Lynceus SAS
LYNCEUS SAS
6 patents
- Lyvgen Biopharma…
LYVGEN BIOPHARMA HOLDINGS LIMITED
6 patents
- Laaser Critical C…
LaaSer Critical Communications Corp.
6 patents
- LUX BIO Group ◀
LUX BIO GROUP INC.
6 patents
What this shows LUX holds 6 patents at rank #41,393, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near LUX
By rank, the assignees closest to #41,393 in granted patent volume.
- Luminous Cyber Corporation #41,389 · 6 patents
- Lumos LABS, Inc. #41,390 · 6 patents
- Lumosa Therapeutics Co., Ltd #41,391 · 6 patents
- LURE Enterprises Limited Liability Company #41,392 · 6 patents
- LWE, Inc. #41,394 · 6 patents
- Lynceus SAS #41,395 · 6 patents
- Lyvgen Biopharma Holdings Limited #41,396 · 6 patents
- Laaser Critical Communications Corp. #41,397 · 6 patents
Leaders in B82Y (Specific USES OR Applications OF Nanostructures)
Other assignees with the most granted patents in LUX's primary technology class.
- Taiwan Semiconductor Manufacturing Company Ltd. 1,724 in class
- International Business Machines Corporation 1,056 in class
- Intel Corporation 466 in class
- The Regents Of The University Of California 315 in class
- Tsinghua University 241 in class
- HON HAI Precision Industry Co., Ltd. 237 in class
- Massachusetts Institute Of Technology 207 in class
- Commissariat A L'energie Atomique ET AUX Energies Alternatives 171 in class
LUX's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
24 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 16.7% |
| 2016 | 1 | 16.7% |
| 2017 | 2 | 33.3% |
| 2019 | 2 | 33.3% |
Which technologies does LUX BIO Group Inc. patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does LUX BIO Group Inc. hold?
LUX BIO Group Inc. holds 6 US granted patents filed between 2015 and 2019, spanning 5 technology areas.
What is LUX BIO Group Inc.'s Innovation Score?
LUX BIO Group Inc. has an Innovation Score of 24.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does LUX BIO Group Inc. focus on?
LUX BIO Group Inc.'s top technology area is B82Y (SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES) with 6 patents. The company has filed patents in 5 CPC subclasses total.
Is LUX BIO Group Inc.'s patent filing rate increasing or decreasing?
LUX BIO Group Inc.'s recent filing velocity is -100% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for LUX BIO Group Inc.'s patents?
LUX BIO Group Inc.'s patents average 16.3 claims each. This falls within the standard range, providing solid legal coverage.
How is the LUX BIO Group Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
LUX's 6 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - LUX ranks #41,393 of 50,000. Top 50 holders
- Most of this portfolio concentrates in B82Y - see who else leads that technology area. B82Y leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.